Researchers have engaged with smokers with MS to understand their attitudes towards quitting smoking and whether their support needs are met by currently available assistance.
Researchers have used a unique screening process to repurpose approved drugs for other diseases for the repair of myelin in progressive MS.
Melissa Quirk was 27 years old when she was diagnosed with MS in 2015. We are excited to have Melissa as our newest Kiss Goodbye to MS Ambassador.
Multiple sclerosis (MS) is a neurodegenerative disease directed by the immune system which can causes symptoms such as pain.
MS Australia is delighted to announce its second community partnership with Jean Hailes for the annual health awareness campaign, Women’s Health Week.
MS Australia has announced the appointment of four independent skills-based Board Directors and the retirement of two longstanding Directors.
Pharmaceutical company Sanofi have advised that their MS disease modifying therapy Aubagio will be delisted from the Australian market from October 2021.
MS Australia has received a major funding boost of $7.4 million from MSWA, which is the largest single donation received by MS Australia from any donor.
Australian researchers and disease-based charities are working together to promote and simplify access to evidence-based stem cell therapies in Australia.
